Home FDA approves Novo Nordisk's weight loss injection, Saxenda
 

Keywords :   


FDA approves Novo Nordisk's weight loss injection, Saxenda

2014-12-26 06:37:52| Biotech - Topix.net

Novo Nordisk today announced that the Food and Drug Administration has approved the new drug application for Saxenda , the first once-daily glucagon-like peptide-1 receptor agonist for chronic weight management. Saxenda is indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with obesity or who are overweight in the presence of at least one weight-related comorbid condition.

Tags: loss weight novo injection

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
26.11RMX2020 TMX-420U25S
26.11DS LL()
26.1120c5000xg
26.11
26.11 SLS2000
26.11 119
26.1110th
26.11 VESPA sprint GL150200 PIAGGIO
More »